What is the global market size of Nuclear Medicine Market?

Nuclear Medicine Market size was valued at USD 10.2 Billion in 2023 and is poised to grow from USD 11.53 Billion in 2024 to USD 25.12 Billion by 2032, growing at a CAGR of 13.00% during the forecast period (2025-2032).

What are the key segments in the Nuclear Medicine Market?

The market is segmented by Diagnostics (SPECT, PET), Therapeutics (Alpha Emitters, Beta Emitters, Brachytherapy Isotopes), Application (Oncology, Cardiology, Neurology, Others), End User (Hospitals, Diagnostic Centers, Research Institutes), and Region.

What is driving growth in the Nuclear Medicine Market?

Key drivers include the rising incidence of cancer and cardiovascular diseases, technological advancements in nuclear imaging, and a robust product pipeline.

Which region accounted for the largest share in the Nuclear Medicine Market?

North America holds the largest share of the Nuclear Medicine Market, driven by advanced healthcare infrastructure and high prevalence of target diseases.

Nuclear Medicine Market Updates

Name: Nuclear Medicine Market By Diagnostics (SPECT, PET), Therapeutics (Alpha Emitters, Beta Emitters, Brachytherapy Isotopes), Application (Oncology, Cardiology, Neurology, Others), End User (Hospitals, Diagnostic Centers, Research Institutes), By Region - Industry Forecast 2025-2032
Brand: SkyQuest Technology

Skyquest Technology's expert advisors continuously track and analyze the latest developments and updates related to nuclear medicine market. Our team of analysts stay abreast of all the recent news stories shaping the industry including new product launches by major companies, strategic partnerships, M&As, Patent filings and industry and regulatory developments.

Nuclear Medicine Market News

in Nuclear Medicine Market

In December 2024, GE HealthCare completed acquiring the remaining 50% stake in Nihon Medi-Physics, a leading Japanese radiopharmaceutical company. This acquisition strengthens GE’s molecular imaging presence in Japan’s lucrative market, enhances its diagnostic radiopharmaceutical portfolio, and supports precision care strategies across Asia. The move expands GE’s footprint in the fast-growing nuclear medicine sector.

In December 2024, Siemens Healthineers finalized the acquisition of Advanced Accelerator Applications from Novartis. This deal grants Siemens access to 13 PET radiopharmaceutical manufacturing sites across Europe, significantly enhancing its supply capacity for critical cancer imaging and theranostic agents. The acquisition boosts Siemens’ leadership in nuclear medicine and broadens its global radiopharmaceutical network.

In December 2024, Cardinal Health began routine commercial-scale production of actinium-225 (Ac-225) at its Center for Theranostics Advancement in Indianapolis. This achievement makes Cardinal the first company to provide cGMP-compliant Ac-225 regularly, a key isotope in targeted alpha therapies for cancer. This milestone accelerates availability of advanced radiopharmaceuticals, supporting growth in precision oncology treatments worldwide.

Nuclear Medicine Market Report Snapshots

REPORT OVERVIEW BUY NOW

REQUEST FOR SAMPLE

Want to customize this report?

REQUEST FREE CUSTOMIZATION

FAQs

Global Nuclear Medicine Market size was valued at USD 10.2 Billion in 2023 poised to grow between USD 11.53 Billion in 2024 to USD 25.12 Billion by 2032, growing at a CAGR of 13% in the forecast period (2025-2032).

The global nuclear medicine market outlook is highly competitive, with key players like GE HealthCare, Siemens Healthineers, Cardinal Health, and Curium leading innovation. Companies focus on strategic partnerships, product launches, and expanding radiopharmaceutical portfolios to strengthen market position. For example, GE HealthCare invests in AI integration for imaging solutions, while Cardinal Health emphasizes supply chain optimization and expanding its radiopharmaceutical manufacturing capacity, driving growth and enhancing global reach in this evolving market.'GE HealthCare (USA)', 'Siemens Healthineers (Germany)', 'Cardinal Health (USA)', 'Curium (France)', 'Jubilant Life Sciences (India)', 'Lantheus Holdings (USA)', 'Bracco Imaging (Italy)', 'Philips Healthcare (Netherlands)', 'Advanced Accelerator Applications (France)', 'Nihon Medi-Physics (Japan)', 'Spectrum Pharmaceuticals (USA)', 'Ion Beam Applications (IBA) (Belgium)', 'Eckert & Ziegler (Germany)', 'ABX Advanced Biomedical Compounds (Germany)', 'Sofie Biosciences (USA)'

The rising global incidence of cancer significantly drives the nuclear medicine market. Nuclear imaging techniques like PET and SPECT enable early tumor detection, accurate staging, and treatment monitoring. Growing awareness and demand for precision diagnostics in oncology are boosting adoption rates, fueling market expansion worldwide.

Rising Adoption of Theranostics: Theranostics, combining diagnostic imaging with targeted radiopharmaceutical therapy, is rapidly transforming the global nuclear medicine market trends. By enabling personalized treatment plans through precise tumor detection and simultaneous therapy, it drives demand for innovative radiotracers and expands clinical applications, particularly in oncology, enhancing patient outcomes and market growth.

How does the Presence of Key Industry Players Impact the Market in North America?

Feedback From Our Clients

"We have purchased recently a report from SkyQuest Technology, and we are happy to inform you that this report was so useful and practical for our team. Skyquest Team was very active and our queries were followed up completely.It was amazing. "

- Mr. Ali Zali, Commercial Director, ICIIC Iran.

Nuclear Medicine Market Updates

Nuclear Medicine Market News

Nuclear Medicine Market Report Snapshots

FAQs

What is the global market size of Nuclear Medicine Market?

Who are the key vendors in the Nuclear Medicine Market?

What is the key driver of Nuclear Medicine Market?

What is the key market trend for Nuclear Medicine Market?

Which region accounted for the largest share in Nuclear Medicine Market?

Request Free Customization